Mazdak A. Khalighi
No Rating Available
(Learn About Our Rating System)

Mazdak A. Khalighi, MD

Languages spoken: English

Dr. Mazdak Khalighi is a board certified anatomic pathologist. He completed a residency in anatomic pathology at the University of California, Los Angeles, where he also served as chief resident. He subsequently completed a fellowship in medical renal pathology at the University of Chicago, where he gained an interest in immunology and autoimmune disease as well as immunofluorescence and electron microscopy. He joined the derpartment of dermatology within the immunodermatology laboratory at the University of Utah with particular interest in autoimmune disease affecting the skin and mucous membranes.

Specialties

Board Certification

American Board of Anatomic Pathology

Dr. Mazdak Khalighi is a board certified anatomic pathologist. He completed a residency in anatomic pathology at the University of California, Los Angeles, where he also served as chief resident. He subsequently completed a fellowship in medical renal pathology at the University of Chicago, where he gained an interest in immunology and autoimmune disease as well as immunofluorescence and electron microscopy. He joined the derpartment of dermatology within the immunodermatology laboratory at the University of Utah with particular interest in autoimmune disease affecting the skin and mucous membranes.

Board Certification and Academic Information

Academic Departments Dermatology -Assistant Professor (Clinical)
Pathology -Adjunct Assistant Professor
Board Certification
American Board of Anatomic Pathology

Education history

Undergraduate Cellular and Molecular Biology - University of Michigan B.S.
Professional Medical Medicine - Jefferson Medical College M.D.
Internship Pediatrics - Stanford University Hospitals Intern
Residency Anatomic Pathology - University of California, Los Angeles Resident
Chief Resident Anatomic Pathology - University of California, Los Angeles Chief Resident
Fellowship Renal Pathology - University of Chicago Fellow
Fellowship Surgical Pathology - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Khalighi MA, Snook JP, Cocks MM, Leiferman KM, Wada DA, Zone J (2026). Diffuse Dermal Immunoglobulin Deposition and Monoclonal Gammopathy. JAMA dermatology,
  2. Stone CJ, Nicholson L, Florell SR, Khalighi MA, Lewis BK (2023). A case of secondary syphilis presenting like pemphigus with positive direct immunofluorescence. JAAD case reports, 42, 38-41.
  3. Leiferman KM, Snook JP, Khalighi MA, Kuechle MK, Zone J (2022). Diagnostics for Dermatologic Diseases with Autoantibodies. The journal of applied laboratory medicine, 7(1), 165-196.
  4. Daines B, Madigan LM, Vitale PA, Khalighi M, Innes (2022). A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination. Dermatology online journal, 28(4),
  5. Khalighi MA, Gallan AJ, Chang A, Meehan S (2018). Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases. American journal of kidney diseases, 72(4), 612-616.
  6. Mansour SG, Hall IE, Reese PP, Jia Y, Thiessen-Philbrook H, Moeckel G, Weng FL, Revelo MP, Khalighi MA, Trivedi A, Doshi MD, Schröppel B, Parikh C (2018). Reliability of deceased-donor procurement kidney biopsy images uploaded in United Network for Organ Sharing. Clinical transplantation, 32(12), e13441.
  7. Lloyd IE, Ahmed F, Revelo MP, Khalighi M (2018). De novo immune complex deposition in kidney allografts: a series of 32 patients. Human pathology, 71, 109-116.
  8. Khalighi MA, Al-Rabadi L, Chalasani M, Smith M, Kakani S, Revelo MP, Meehan S (2018). Staphylococcal Infection-Related Glomerulonephritis With Cryoglobulinemic Features. Kidney international reports, 3(5), 1128-1134.
  9. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Meehan SM, Chang (2016). Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy. Clinical kidney journal, 9(3), 397-402.
  10. Lloyd IE, Gallan A, Huston HK, Raphael KL, Miller DV, Revelo MP, Khalighi M (2016). C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. Clinical kidney journal, 9(6), 794-799.
  11. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Chang A, Meehan S (2015). Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Pediatric nephrology (Berlin, Germany), 30(6), 953-9.
  12. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng, J, Rastogi A, Chen W, Grossman J (2012). American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis care and research, 64(6), 797-808.
  13. Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed E (2011). Apolipoprotein A1 and C-terminal fragment of ¿-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection. Transplantation, 92(4), 388-95.

Review

  1. Khalighi MA, Chang (2021). Infection-Related Glomerulonephritis. Glomerular diseases, 1(2), 82-91.

Case Report

  1. Jimenez A, Blain K, Khalighi M, Clarke JT, Snook J, Cipriano S (2021). Neonatal pemphigoid gestationis: An atypical presentation of a rare disease. Pediatric dermatology, 38(6), 1575-1576.
  2. Kukull BJ, Khalighi MA, Gundle KR, Hansford BG, Corless CL, Davis J (2020). Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient. Pediatric and developmental pathology, 23(3), 240-246.